Publikationen & Präsentationen

Swiss Chinese Life Sciences Forum 2022

On March 16, 2022, the online Swiss Chinese Life Sciences Forum is going to take place for the fifth time, co-organized in collaboration of SCCC, Basel Area Business & Innovation and VISCHER AG.

SCCC Legal Chapter 2021 Forum

Speakers: Lukas Züst, Qinqin Yao Organizer: Swiss Chinese Chamber of Commerce Location: Zurich

On 22 September 2021, Lukas Zuest and Qinqin Yao of our China Desk gave a presentation at the SCCC Legal Chapter 2021 Forum on...

Swiss Chinese Life Science Forum 2021

On June 30, 2021, our Head of China Desk Lukas Zuest gave a presentation at the Swiss Chinese Life Sciences Forum 2021 about "China’s new 'dual circulation' strategy – How does it affect life science companies?".

He explained the...

China: The Future Belongs to Innovation

Speaker: Dr. Stefan Kohler Organiser: Swiss China Summit  Location: Rüschlikon

At the Swiss China Summit 2021, Stefan Kohler, Partner at VISCHER AG, moderated the panel with Dr. William Pao, Head of Pharmaceutical Research &...

E-Commerce in China: Finding the Right Platforms, Opportunities and legal challenges for Swiss consumer goods brands

Züst, Lukas, and Yao, Qinqin, E-Commerce in China: Finding the Right Platforms, Opportunities and legal challenges for Swiss consumer goods brands, in: The Bridge, Autumn 2020, Issue 56, page 12.

Venture Leaders China 2020 Kick-Off Workshop

On August 26, 2020, our China and Startup experts Lukas Zuest, Christian Wyss and Gian-Andrea Caprez held a workshop together with the 10 Swiss startups that were selected for the Venture Leaders China 2020 program. 

In the 2...

Legal Options for Swiss Startups

Züst, Lukas / Zhao, Luer, China Market Entry: Legal Options for Swiss Startups, in: THE BRIDGE, Heft 54 (2019), S. 15-17.

The Outlook for Chinese Healthcare

On September 25, 2019, VISCHER Manager of China Life Sciences Group Fiona Gao will give a presentation at the 19th Annual Biotech in Europe Forum. Her topic will be The Outlook for Chinese Healthcare: Changing Regulatory & Policy...

Regulatory Framework of Drug Entry to China

Gao, Fiona, Regulatory Framework of Drug Entry to China, in: Life Sciences Law, Chapter 6, pages 304 – 308, ISBN: 978-3-03891-025-1

Order the book

Trade, Investment and M&A in Switzerland – Key Factors for Chinese Enterprises

Key Factors for Chinese Enterprises. Switzerland has become a major jurisdiction for Chinese enterprises that are looking for direct investments in Europe, establishing European headquarters, distribution centers, R&D-centers, and acquiring European high-class know-how.